65
Views
11
CrossRef citations to date
0
Altmetric
Original Research

The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women

, &
Pages 1401-1407 | Published online: 24 Jul 2014

References

  • PayneJFHubbardGBIIIAabergTMSrYanJClinical characteristics of hydroxychloroquine retinopathyBr J Ophthalmol201195224525020693556
  • WolfeFMarmorMFRates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosusArthritis Care Res (Hoboken)201062677578420535788
  • LevyGDMunzSJPaschalJCohenHBPrinceKJPetersonTIncidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practiceArthritis Rheum1997408148214869259429
  • BrowningDJHydroxychloroquine and Chloroquine Retinopathy: Screening for Drug ToxicityAm J Ophthalmol2002133564965611992862
  • MarmorMFComparison of screening procedures in hydroxychloroquine toxicityArch Ophthalmol2012130446146922159170
  • BrowningDJImpact of the revised American academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practiceAm J Ophthalmol2013155341842823218706
  • WalvickMDWalvickMPTongsonENgoCHHydroxychloroquine: lean body weight dosingOphthalmology201111810210021968180
  • MichaelidesMStoverNBFrancisPJWeleberRGRetinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapyArch Ophthalmol20111291303921220626
  • MackenzieAHDose refinements in long-term therapy of rheumatoid arthritis with antimalarialsAm J Med1983751A40456869410
  • BrowningDJReply to Defining Ideal Body WeightAm J Ophthalmol2002134693593612470778
  • BernsteinHNOcular safety of hydroxychloroquine sulfate (Plaquenil)South Med J19928532742791546352
  • PaiMPPaloucekFPThe origin of the “Ideal” body weight equationsAnn Pharmacother20003491066106910981254
  • YamJCKwokAKOcular toxicity of hydroxychloroquineHong Kong Med J200612429430416912357
  • SundelinSPTermanADifferent effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cellsAPMIS2002110648148912193209
  • JohnsonMWVineAKHydroxychloroquine therapy in massive total doses without retinal toxicityAm J Ophthalmol198710421391443618711
  • BergholzRSchroeterJRutherKEvaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquineBr J Ophthalmol201094121637164220940312
  • NowaczykPMurawaDPolomKAnalysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulasLangenbecks Arch Surg2012397577978622415154
  • ShahBSucherKHollenbeckCBComparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United StatesNutr Clin Pract200621331231916772549
  • SchwartzSGMielerWFRetinal and Choroidal Manifestations of Systemic MedicationsArevaloJFRetinal and Choroidal Manifestations of Selected Systemic DiseasesNew YorkSpringer2013479492
  • FungAESamyCNRosenfeldPJOptical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathyRetinal Cases and Brief Reports200713128130
  • MarmorMFCarrREEasterbrookMRecommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology200210971377138212093666
  • StepienKEHanDPSchellJGodaraPRhaJCarrollJSpectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision lossTrans Am Ophthalmol Soc2009107283420126479
  • ElderMRahmanAMMcLayJEarly paracentral visual field loss in patients taking hydroxychloroquineArch Ophthalmol2006124121729173317159032
  • MavrikakisISfikakisPPMavrikakisEThe incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine – a reappraisalOphthalmology200311071321132612867385
  • MavrikakisMPapazoglouSSfikakisPPVaiopoulosGRougasKRetinal toxicity in long term hydroxychloroquine treatmentAnn Rheum Dis19965531871898712882
  • AndersonCBlahaGRMarxJLHumphrey visual field findings in hydroxychloroquine toxicityEye (Lond)201125121535154522094300
  • ThorneJEMaguireAMRetinopathy after long term, standard doses of hydroxychloroquineBr J Ophthalmol199983101201120210636653
  • TeohSCLimJKohALimTFuEAbnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retinotoxicityEye (Lond)200620112913215731769
  • AndersonCPahkPBlahaGRPreferential hyperacuity perimetry to detect hydroxychloroquine retinal toxicityRetina20092981188119219491724
  • FalconePMPaoliniLLouPLHydroxychloroquine toxicity despite normal dose therapyAnn Ophthalmol199325103853888304691
  • BienfangDCoblynJSLiangMHCorzilliusMHydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive seriesJ Rheumatol200027112703270611093457
  • WarnerAEEarly hydroxychloroquine macular toxicityArthritis Rheum20014481959196111508449
  • WeinerASandbergMAGaudioARKiniMMBersonELHydroxychloroquine retinopathyAm J Ophthalmol199111255285341951589
  • KellnerSWeinitzSKellnerUSpectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescenceBr J Ophthalmol200993111444144719692385
  • KellnerURennerABTillackHFundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquineInvest Ophthalmol Vis Sci20064783531353816877425
  • ChenEBrownDMBenzMSSpectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign)Clin Ophthalmol201041151115821060664
  • Rodriguez-PadillaJAHedgesTRIIIMonsonBHigh-speed ultrahigh-resolution optical coherence tomography findings in hydroxychloroquine retinopathyArch Ophthalmol2007125677578017562988
  • KelmensonATBrarVSMurthyRKChalamKVFundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathyEur J Ophthalmology2010204785788
  • ReedHKarlinskyWDelayed onset of chloroquine retinopathyCan Med Assoc J19679723140814116060846
  • MarmorMFKellnerULaiTYYLyonsJSMielerWFAmerican Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011118241542221292109
  • BernsteinHNOphthalmologic considerations and testing in patients receiving long-term antimalarial therapyAm J Med1983751A25346869408
  • McDowellMAFryarCDOgdenCLFlegalKMNational Health Statistics ReportsAnthropometric reference data for children and adults: United States 2003–20062008 Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr010.pdfAccessed June 25, 2014
  • MarmorMFEfficient and effective screening for hydroxychloroquine toxicityAm J Ophthalmol2013155341341423394729
  • BrowningDJReply to Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practiceAm J Ophthalmol2013156241041123870364
  • BrowningDJHydroxychloroquine and Chloroquine RetinopathyFirst editionNew YorkSpringer2014